ROMK gene (KCNJ1) mutations cause Bartter syndrome type II (hypokalemic alkalosis), whose pathological phenotype mirrors ROMK inhibition in DKD as a “mirror phenomenon.” The lack of selective ROMK inhibitors has hindered therapeutic exploration. Here, KCNJ1 is linked to diabetic kidney disease.